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The Legitimacy of Peer
Reviewing
When it comes to the distribution of
scarce funding resources for research in the
biosciences, peer review has long been the
undisputed champion of decision making.
In recent years, its importance has only
been enhanced, as many funding agencies
increasingly distribute research funds
through competitive instruments, and ac-
quiring research funding is more important
than ever for success in all branches of
science [1,2]. Today, peer reviewing has
gained as much legitimacy in the scientific
world as well as among lay public. Directed
at the scientific community, it stands for
fairness and objectivity in the distribution of
grants; to the general public, it guarantees
awarding of public (taxpayer) funds along
scientific values rather than political ones.
Robustness of procedure and efficiency of
distribution are the two pillars on which the
legitimacy of the peer review rests.
That is not to say that everything is
perfect with peer reviewing. Studies point to
a series of constraints. For example, grading
of grant applications was shown to substan-
tially differ among reviewers, a problem
particularly common in biosciences [3];
moreover, reviewers differ in the weight
they give to research originality, methodol-
ogy, and feasibility [4]. An NSF experiment
[5] found that grant reviewers who evaluat-
ed shorter, anonymized proposals selected a
substantially different set of projects for
funding than those chosen by reviewers
presented with standard, full-length versions
of the same proposals. Another study
indicates that projects with high marks in
the review process produce just as many
publications (and citations) as projects with
lowmarks [6]. And in a 2010 survey of grant
reviewers, 85% felt they had not been
sufficiently trained in grant review [7].
Opening up the ‘‘black box of peer
reviewing’’ [8] allows funding agencies to
take counter measures against what was
spotted in those studies as weak features of
their procedures, and to upgrade accom-
panying methods. We see, for example,
that funders have lately put more emphasis
on properly training the peer reviewers or
on implementing more robust conflict of
interest rules [9,10]. In a nutshell, thus,
funding agencies have done a remarkable
job of increasing the robustness of their
procedure by making it more and more
elaborate.
The larger developments, such as the
changing relationship between science and
society, and the increased role that peer
reviewing plays in the daily work of an
average researcher, have not found the
attention of funding agencies, though. As
for the former, scientifically produced
knowledge plays an extremely important
role in our lives. It has become the basis of
our economic growth; it has revolution-
ized the ways with which we perceive our
body, our mind, our society. At the same
time, and unlike what one would expect
from solid scientific knowledge, this has
not made societies more resilient or secure.
On the contrary, the controversies over
scientifically established knowledge have
become harsher (think of climate change),
and some sociologists of science call it now
the age of uncertainty [11,12].
What does that have to do with peer
reviewing? A lot, actually. The ever
growing competition on limited biomedi-
cal research funding means that more
scientists submit applications for each call
every year, further straining the peer
review process. In the United States, the
success rate of NIH grants combined has
fallen from 34% in 2001 to 19% in 2012,
while that of new targeted proposals fell
from 28% to 14% during the same period
[13]. Similar trends are evident across the
globe; grant application success rates for
many public funding agencies in 2012
were below 25% (Table 1). As success
rates of funding opportunities are declin-
ing, writing and reviewing grant proposals
is consuming more time of academic
researchers than ever; a recent survey
found that writing a new grant application
for The National Health and Medical
Research Council of Australia took prin-
cipal investigators (PIs) 38 working days on
average [14]. Considering that many
academic researchers submit several grant
applications every year, this means that
much of the knowledge produced by and
exchanged among researchers nowadays
gravitates around peer review procedures,
either as proposals or as reviews [15].
With scientific knowledge production
being increasingly enabled through peer
review, and this knowledge often playing
part in societal dynamics, procedural
robustness and distributive efficiency of
public research funding may lose their
bite. A recent metastudy has concluded
that ‘‘there is little empirical evidence on
the effects of grant giving peer review’’
[16]. Similarly, concern about research
integrity and scientific misconduct indi-
cates that robustness alone no longer yields
sufficient legitimacy for peer reviewing.
Critics of the current system suggest
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thinking about drastic alternatives [17,18],
and the Open Science movement [19,20]
seeks a radical transformation of the
decision-making procedures in science. In
most of those accounts, transparency is
entering center stage.
Transparency, however, can mean two
very different things. It can mean that
some knowledge within the peer reviewing
procedure is openly accessible, while other
information is kept away from the public.
In such an understanding, transparency is
supposed to buttress the existing two
pillars of legitimacy, robustness of the
procedure and efficiency of distribution.
Or it can mean that transparency of
knowledge is emerging as a new, third
pillar of legitimacy that is indispensable for
peer reviewing to retain its pivotal func-
tion. From that perspective, transparency
of knowledge would have the potential of
radically transforming peer reviewing. We
can distinguish those two perspectives as
incremental versus radical approaches
towards transparency.
How do funding agencies currently
apply transparency? Not surprisingly, as
we will see, their perspective on that issue
is almost exclusively an incremental one.
Still, a comparative look at transparency
policies of leading biomedical funding
agencies across the world (Table 1) will
help us to understand differences, defi-
ciencies, and potential improvements. It
will also guide our discussion following this
empirical analysis, which we will divide
first, to make concrete suggestions for
improving transparency measures from
an incremental perspective and second,
to discuss, more speculatively, the trans-
formative potential of transparency when
applied under the radical perspective.
Transparency Policies at
Funding Agencies
What does transparency mean when it
comes to peer reviewing grant applica-
Table 1. Major public funding agencies, annual funding levels, application success rates, and published details of the assessment
process.
Agency (Country)
(last annual report)
Total annual
funding
(million US$)*
Success rate
biomedical/life sciences Abstract Funding
Assessment
summary Final report
NIH (USA) (2013) 30100 14% (Medical research, 2012) Yes Yes No No
NSF (USA) (2013–2014) 7170 22% (General, 2013) Yes Yes No No
Wellcome Trust (UK)
(2012–2013)
3945 25% (General, 2012–2013) No Yes No No
JSPS (Japan) (2012–2013) 3171 30.3% (General, 2012) Yes Yes No Yes
DFG (Germany) (2013) 3160 28.3% (Life Sciences) Yes No No No
NSFC (China) (2011) 2976 16.9% (Health Science, 2011)
20.9% (Life Sciences, 2011)
Yes Yes No No
ERC (European Union) (2013) 2150 12% Yes Yes No No
MRC (UK) (2013–2014) 1357 21.6% (2013–2014) Yes Yes No No
CONACyT (Mexico) (2012) 937 NR No Yes No No
NSERC (Canada) (2012–2013) 933 NR for Biomedical/Life Sciences No Yes No No
CSIC (Spain) (2013) 894 NR No No No No
SNF (Switzerland) (2012) 789 50% No No No No
BBSRC (UK) (2013–2014) 777 27% Yes Yes No No
NHMRC (Australia) (2013) 748 20.5% Yes Yes No Yes
Vetenskapsradet (Sweden) (2012) 691 NR Yes Yes No No
ANR (France) (2013) 548 16.5% (General) Yes Yes No No
Academy of Finland (Finland)
(2014)
395 17% (Health research, 2012) Yes Yes No No
ZonMW (Netherlands) (2011) 364 NR Yes Yes No No
NCN (Poland) (2013) 302 22% (Life Sciences) No Yes No No
FWF (Austria) (2013) 258 30.2% (General, 2012) Yes No No No
FNRS (Belgium) (2012) 225 36.9%-38.2% (2011) No No No No
DFF (Denmark) (2013) 205 23% (Medical science);
19% (General)
Yes Yes No No
RFBR (Russian Federation) (2013) 200 NR Yes No No Yes
Ministry of Health (Italy) (2012) 171 NR No Yes No No
CIRM (USA) (2013) 163 42.8% Yes Yes No Yes
ISF (Israel) (2014) 136 32.8% (General) No Yes No No
HFSP (International) (2012–2013) 117 9% Yes No No No
*Arranged by decreasing total annual funding.
Funding levels and success rates are the latest as available on the funding agencies websites on October 10. 2014, rounded to nearest million US$ according to
exchange rates on that day. NR: not reported.
doi:10.1371/journal.pbio.1002010.t001
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tions? As different as the various public
funding distribution modes may be, each
peer review procedure typically involves a
set of stages in which different knowledge
items are involved. Those items can be
categorized in four types: the knowledge
regulating the procedure (funding agency
rules), the knowledge that is examined
(application content), the knowledge that is
applied (expertise for evaluation), and the
knowledge that is a result of the procedure
(final assessment) (Table 2). Funding agen-
cies can deal with those knowledge items
in terms of access: open, if publicly
available; restricted, if available only to a
defined group of people; and closed, if not
available at all; as well as timing: providing
access to a knowledge item either before
the evaluation procedure, during the
procedure, or after the procedure. They
define where to draw the line between
containing knowledge and making it
openly available, and when.
For example, describing the basic fea-
tures of the procedure on the website of
the funding agency before the submission
deadline of a call means that the agency
treats this particular feature of information
in an open way. The way one funding
agency deals with the knowledge items in
terms of access and timing constitutes its
transparency policy. In order to assess
different takes for the above knowledge
items, we carefully examined the websites
of 27 major public funding agencies
around the world [20,21]; (Table 1). To
the best of our knowledge, such a
comparative global survey has not been
previously reported (a small survey of ten
United Kingdom public agencies was
recently reported [22]. The results of our
survey tell us more about policies of
individual public research funding agen-
cies; they also allow us to make some
comparison across the board and to
identify best practice policies.
Unsurprisingly, transparency policies
are very similar when it comes to impart-
ing the general rules of the grant applica-
tion and evaluation procedure. Similarly,
the principles of the peer review procedure
are made available openly, an issue
coordinated also by the recently installed
Global Research Council [23]. Once the
peer review process is concluded, and the
funding decision is made, most surveyed
funding agencies publish on their website a
list of projects selected for funding for each
call, along with names of PIs and their
affiliations and amount of funding, as well
as the overall success rate of the call.
Eighteen of the 27 surveyed public funding
agencies also publish the scientific ab-
stracts of successful applications (Table 1).
Other items are generally restricted by
nearly all surveyed agencies. The final
assessment of grants (either the result from
discussion of individual reviews by the
scientific review panel together with the
results of the evaluation, or, where no review
panel exists, simply the synopsis of the
individual reviews) is sent by most agencies
directly to the applicant. None of the
surveyed funding bodies publishes the final
assessment of funded proposals; albeit, one of
them, the California Institute for Regenera-
tive Medicine (CIRM; Table 1) publishes a
‘‘Statement of Benefit to California’’ as well
as annual progress reports written by the
authors (for example see: http://www.cirm.
ca.gov/our-funding/application-reviews-
rfagenomicsgc1r-06673). Adopting a com-
mon policy of publishing the final assessments
would allow unsuccessful applicants the
opportunity to see whether their ambitions
are vindicated and, potentially, to improve
their proposal based on the feedback. It will
also allow the public insight into reasons for
selecting certain proposals for funding.
Openly published, but only after the
review procedure has been concluded, are
some of the items belonging to the
expertise category. Only one of the
surveyed agencies, the Swedish Research
Council (Vetenskapsradet), discloses the
names of the reviewers before the evalu-
ation procedure of a given call. All other
funding agencies surveyed do not disclose
the names of the reviewers beforehand;
apparently such policy intends to block
attempts by tentative applicants to manip-
ulate the peers. Similar to the practice of
many scientific journals of publishing a list
of their manuscript reviewers at the end of
each year (for example, [24]), some
funding bodies, such as the European
Research Council (ERC), publish the
names of the reviewers once the review
process is over. While most public grant
agencies require PIs to submit final reports
after the project is concluded, only four of
the 27 surveyed agencies currently publish
them on their websites (Table 1). Not
published at all are the names of unsuc-
cessful applicants and their proposals.
Incremental Perspective: How
to Improve Effectiveness and
Robustness Further through
Transparency
Our survey provides only a narrow
picture, but it makes very clear that all
funding agencies at their core employ a
transparency policy that is primarily
concentrated on providing more informa-
tion about the rules of the game, and
results of the procedure, while they
contain scientific knowledge that is genu-
inely fed into the process (and is paid for
by public money, as reviewers and panel
members are often paid for their work), as
well as knowledge that is applied to assess
that content. Transparency, hence, is
primarily a means to increase the robust-
ness of the procedure and (to a lesser
extent) pinpoint the efficiency of distribu-
tion. That is probably why funding
agencies are rather transparent when it
comes to knowledge items related to rules
and procedures, but reluctant when it
comes to items related to content and
expertise categories.
It is important to reflect the thinking of
funding agencies behind that specific
pattern of regulations towards the different
Table 2. Knowledge items.
Item Knowledge category
Description of evaluation procedure Rules
Evaluation details (questions to the reviewers) Rules
Names of applicants Content
Names of funded PIs Content
Proposals submitted to call Content
Proposals/Lay Abstracts of funded projects Content
Names of reviewers (at minimum, in aggregated form) Expertise
Review summaries of all proposals Expertise
Review summaries of funded proposals Expertise
Funding budget granted to projects Produce
Call success rate Produce
Ranking of proposals Produce
Final report (at minimum, the Final Report Abstract) Produce
doi:10.1371/journal.pbio.1002010.t002
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knowledge items involved in their peer
reviewing. Apparently, it goes like this: as
distributors of public funds, they need to
make sure that their funding decision
making is fair and objective—that it is
fairly accessible by everyone eligible, that
it is conducted under comprehensive
conditions (without favoring someone),
and that the funds are used in an
accountable manner. At the same time,
funders assume that for certain knowledge
involved in the process (most notably, the
proposals and the reviews), researchers
may prefer to not be in public domain
until they have published the resulting
findings; as conventional wisdom goes,
their unrestrained dissemination would
conflict with researchers’ interests of
keeping their research ideas, novel tech-
nologies, and preliminary findings confi-
dential until their publication in scientific
journals. In addition, open access to
individual grant review reports may dam-
age reviewers and discourage honest
review.
The apparent thinking here reflects the
current system of academic research by
and large. New scientific knowledge is
mostly produced in a competitive mode
between PIs. Funding for research is based
on a meritocratic system, and peer review-
ing is an essential instrument in establish-
ing what Robert Merton once called the
‘‘stratification system of science’’ [25].
Accordingly, in instances where informa-
tion provided is restricted (as in the case of
the reviews) or delayed (as in the case of
the review panel members), funders ap-
parently intend to protect the reviewers
and the scientific panel members either
from interference (applicants attempting to
manipulate them) or from criticism (appli-
cants criticizing them for unjust assess-
ment). When it comes to the unsuccessful
applicants and their proposals, the general
assumption is that they are better off by
being shielded from the public, as well as
their peers, because of risk to their
reputation.
Let us follow for a moment this
prevalent logic. Even from the incremental
perspective, we can think of at least three
measures that agencies across the world
could implement quickly and without any
hesitation. All are ex post approaches and
should not do any harm on the evaluation
procedure at all. One concerns the
publication of the members of the review
panels (and cumulative list of external
reviewers for a specific call); this would
again enhance the robustness of the peer
review system, as it highlights that the
peers selected for reviewing were compe-
tent and would indicate to potential
applicants that their specific field of
research is well covered.
Second, funding agencies may also want
to consider publishing the ‘‘Impact State-
ment’’ (or similar) that is currently includ-
ed as part of a grant application by many
funding bodies. Publishing these sections
allows the general public insight into grant
selection priorities. Better transparency of
the grant funding selection process would
enable researchers and the public to have
a better understanding of how public
money is spent on scientific research; it
will contribute to improved public trust in
scientific research integrity while creating
a new intersection for public engagement
with scientific research without being
detrimental to its quality or to peer review
integrity.
The third suggestion concerns the
publication of the final reports of funded
projects. Publishing the final reports would
harm neither successful grant applicants
nor peer reviewers. Why this policy has
not been established more broadly can
only be explained by institutional inertia.
In any case, we would like to see more
funding agencies adopting this policy, as
this gives the public better insight into the
distributive efficiency of public money
expenditure (Table 3). Today, final re-
ports are often ‘‘spun’’ in order to comply
with the formal requirements, but are
otherwise written in haste. Making them
public would urge PIs to make them more
comprehensive, yet clear enough for the
public to appreciate the project’s achieve-
ments. The PI would also have to
emphasize more clearly where the conduct
of the project agrees with the original
proposal, and what the reasons were for
taking alternative routes. Thus, overall, it
would increase the quality of this type of
academic publication.
The Radical Perspective:
Transformative Potential of
Transparency
So far, we have followed the apparent
logic of the funders and have made
concrete proposals to improve the imple-
mentation of transparency from an incre-
mental perspective. However, what if we
look at it from the radical perspective,
assuming that transparency of knowledge
would become the third pillar of legitima-
cy of peer reviewing? Even though there is
little empirical evidence, we would expect
at least two major changes. One concerns
the role peer reviewing plays in the
organization of scientific research. To
open up the knowledge items in the
content and expertise, categories would
follow a very practical consideration. With
all the time invested by scientists in writing
reviews that remain basically invisible,
making this valuable work openly accessi-
ble would avoid ‘‘reviewers’ fatigue’’ that
funders often complain about, as reviewers
would know that their laborious contribu-
tion is fully acknowledgeable. Similarly,
readers might find the reviews useful when
assessing the reviewed work by themselves.
The effects of this would be quite trans-
formative: instead of increasing secrecy
and particularism, it would become a hub
for exchange of ideas and data—just as
open review is already benefitting scientific
manuscripts published by journals that
have adopted this policy [18,20,26]. That,
again, would considerably impact academ-
ic hierarchies and publication practices,
among many others.
The other potential change concerns
the role of peer reviewing in structuring
the relation between science and society.
So far, it has primarily served a gatekeep-
ing function, defining who is eligible to
submit and to assess proposals. Under a
new regime, that boundary work would
probably not be eliminated; however, the
dividing line between scientific knowledge
and public participation might become
more permissive, as is already happening
thanks to sharing knowledge through
social networks [27]. Because of its
important role in the academic system,
opening up peer reviewing would be the
most effective lever ‘‘to engage the public
in scientific issues in meaningful ways in
decision-making about the innovation
pathways of biosciences’’ [19]. The im-
portant aspect here, of course, is ‘‘in
meaningful ways’’—that public peer re-
view may increase the quality of both
reviews and submissions is not automati-
cally ensured, but it is worth thinking
about ways to achieve this. Again, the
impact of such an approach would be
sweeping, including the reception of sci-
entific knowledge (and scientists) in the
public, improving public trust in scientific
research.
Admittedly, all that sounds unlikely in
the context of today’s realities, not only
because we lack the evidence, but also
because it is difficult to overcome the
concerns from researchers, reviewers, and
funders alike. Due to the logic prevalent in
academic research, the concerns relate
primarily to competition within the re-
search community. Grant winners fear
that their research ideas, as well as
unpublished data included in their appli-
cations may be used by competitors if
rendered publicly available. Researchers
and their institutions feel uncomfortable
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about risking their intellectual property
(IP) rights. For successful applications, the
risk of a fallout of the project afterwards is
considered too high by reviewers support-
ing it, who could be concerned for their
reputation. As an interim step toward
more radical transparency of grant review,
we believe that openly publishing the final
assessment of the scientific review panel—
currently published by none of the sur-
veyed funding agencies—is the least likely
to cause concerns for reviewers and
funders, while going a long way toward
engaging the public and increasing their
trust in fairness of the grant review process
and thereby in scientific research.
But it seems as if there is an even bigger
concern looming in the background,
namely, that opening up the entire process
to the public might somehow jeopardize its
legitimacy within the scientific communi-
ty. While we understand those concerns,
we would like to stress that the given
system of conducting research is not
necessarily the only one perceivable.
Under the changing conditions empha-
sized in the opening paragraphs, there
might come a situation where peer
reviewing will require a third pillar of
legitimacy, and this would include taking
the radical perspective into account.
Advocates often refer to Winston
Churchill’s bon mot about democracy
and say that, similarly, peer review is
‘‘the worst form of government, except
for all those other forms that have been
tried from time to time’’ [28]. We agree
with that wholeheartedly. But like de-
mocracy, peer review is a principle that
requires specific arrangements in order
to be effective. If funders want to retain
the status of peer reviewing as the fairest
method of distributing funds to re-
searchers, they must embrace transpar-
ency more actively. The definite an-
swers to the operational questions—
which transparency measures to put in
place, and how—will probably only
develop over time and may also depend
on regional patterns of academic cul-
ture. The debate must start here and
now.
Acknowledgments
The authors thank Barbara Prainsack (King’s
College London, UK) and Falk Reckling
(Austrian Science Fund, FWF) for critical
reading of the manuscript and for helpful
comments.
References
1. Heinze T (2008) How to sponsor ground-
breaking research: a comparison of funding
schemes. Sci Public Policy 35: 302–318.
doi:10.3152/030234208X317151
2. Stephan P (2013) How economics shapes science.
Cambridge: Harvard University Press.
3. Mutz R, Bornmann L, Daniel HD (2012)
Heterogeneity of inter-rater reliabilities of grant
peer reviews and its determinants: a general
estimating equations approach. PLoS ONE 7:
e48509. doi:10.1371/journal.pone.0048509
4. Abdoul H, Perrey C, Amiel P, Tubach F, Gottot
S, et al. (2012) Peer review of grant applications:
criteria used and qualitative study of reviewer
practices. PLoS ONE 7: e46054. doi:10.1371/
journal.pone.0046054
5. Bhattacharjee Y (2012) Science funding. NSF’s
‘Big Pitch’ tests anonymized grant reviews. Science
336: 969. doi:10.1126/science.336.6084.969
6. Mervis J (2014) Peering into peer review. Science
343: 596–598. doi:10.1126/science.343.6171.596
7. Schroter S, Groves T, Højgaard L (2010) Surveys
of current status in biomedical science grant
review: funding organisations’ and grant review-
ers’ perspectives. BMC Med 8: 62 doi: 10.1186/
1741-7015-8-62.
8. Lamont M (2009) How Professors Think Inside
the curious world of academic judgment. Cam-
bridge: Harvard University Press.
9. Nowotny H, Exner P (2013) Improving ERC
ethica l s tandards . Science 341: 1043.
doi:10.1126/science.1244098
10. (2014) Full disclosure. Nature 507: 8.
11. Callon M, Lascoumes P, Barthe Y (2009) Acting
in an uncertain world. An essay on technological
democracy. Cambridge: MIT Press.
12. Felt U, Barben D, Irwin A, Joly P-B, Rip A, et al.
(2013) Science in Society: caring for our futures in
turbulent times. ESF Science Policy Briefing 50.
Available: http://www.esf.org/fileadmin/Public_
documents/Publications/spb50_ScienceInSociety.
pdf. Accessed 27 October 2014.
13. NIH Reporter 2013. Available: http://report.nih.
gov/nihdatabook/index.aspx?catid=12. Accessed
27 October 2014.
14. Herbert DL, Barnett AG, Clarke P, Graves N
(2013) On the time spent preparing grant
proposals: an observational study of Australian
researchers. BMJ Open 3: e002800. doi:10.1136/
bmjopen-2013-002800
15. Coryn CLS, Applegate EB, Schro¨ter DC, Martens
KS, McCowen RH (2012) An evaluation of the
transparency and overall quality of evaluation at
the Swiss National Science Foundation: Final
report. Kalamazoo, MI: Western Michigan Uni-
vers i ty . Ava i lable : ht tp ://www.sn f .ch/
SiteCollectionDocuments/Web-News/news-
130221-auswahlverfahren-snf-evaluationsbericht.
pdf. Accessed 27 October 2014.
16. Demicheli V, Di Pietrantonj C (2007) Peer review
for improving the quality of grant applications.
Cochrane Database Syst Rev 18: MR000003.
doi:10.1002/14651858.MR000003.pub2
17. Ioannidis JP (2011) More time for research: fund
people not projects. Nature 477: 529–531.
doi:10.1038/477529a
18. Mietchen D (2011) Peer reviews: make them
public. Nature 473: 452. doi:10.1038/473452b
19. Marris C, Rose N (2010). Open Engagement:
Exploring Public Participation in the Bioscienc-
es. PLoS Biol 8: e1000549. doi:10.1371/jour-
nal.pbio.1000549
Table 3. Recommended incremental transparency measures.
Item Should this item be published?
Abstracts (or lay abstracts) Yes
Impact statements Yes
Full proposals (funded only) No*
Names of external reviewers and scientific review board members Yes, in aggregated form, following the selection process
Detailed (external) reviews No*
Review summaries of failed proposals No
Review summaries of funded proposals Yes
Ranking of proposals Yes, only for funded proposals
Funding budget granted to projects Yes
Call success rate Yes
Final reports Yes
*Starred items may be considered as radical transparency measures; at this time we deem it premature to recommend their open publication by default but would
welcome small-scale experimentation in this area.
doi:10.1371/journal.pbio.1002010.t003
PLOS Biology | www.plosbiology.org 5 December 2014 | Volume 12 | Issue 12 | e1002010
20. Masum H, Rao A, Good BM, Todd MH,
Edwards AM, et al. (2013) Ten Simple Rules
for Cultivating Open Science and Collaborative
R&D. PLoS Comput Biol 9: e1003244.
doi:10.1371/journal.pcbi.1003244
21. OECD (2013) Main Science and Technology
Indicators 2013. Available: http://dx.doi.org/10.
1787/msti-v2013-2-en. Accessed 27 October 2014.
22. van Bekkum JE, Hilton S (2014) UK research
funding bodies’ views towards public partici-
pation in health-related research decisions:
an exploratory study. BMC Health Serv
Res 14: 318. doi:10.1186/1472-6963-14-
318
23. Global Research Council . http://www.
globalresearchcouncil.org/
24. (2013) Reviewer Index: Volumes 193, 194, 195
January–December 2013. Genetics 195: 1423–
1427.
25. Merton RK (1986) The Matthew effect in science.
The reward and communication systems of
science are considered. Science 159: 56.
26. Kumar AH (2014) Open review system: The new
trend in scientific reviewing to improve trans-
parency and overcome biasness. J Nat Sci Biol
Med 5: 231–232. doi:10.4103/0976-9668.
136134
27. van Noorden R (2014) Online collaboration:
Scientists and the social network. Nature 512:
126–129. doi:10.1038/512126a
28. Shanahan DR, Olsen BR (2014) Opening peer-
review: the democracy of science. J Negat Results
Biomed 13: 2. doi:10.1186/1477-5751-13-2.
PLOS Biology | www.plosbiology.org 6 December 2014 | Volume 12 | Issue 12 | e1002010
